Statistics for Caribou Biosciences, (id:8173 CRBU)

Valuation metrics

Market cap

182.92M

Enterprise value

-22,242,680.00

Trailing P/E (ttm)

-1.46

Forward P/E

-1.02

PEG ratio

-1.02

Price/Sales (ttm)

15.94

Price/Book (mrq)

0.65

Enterprise Value/Revenue

-1.94

Enterprise Value/EBITDA

0.14

Overview

Shares outstanding

90.55M

Float

81.58M

Shares short

9.94M

% Held by insiders

0.10%

% Held by institutions

0.63%

Average volume (10 days)

1.52M

Average volume (90 days)

Price summary

52-Week low

1.50

52-Week high

8.33

52-Week change

-184.65%

Beta

2.26

50-Day moving average

2.05

200-Day moving average

3.19

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-1,666.90%

Operational effectiveness

Return on assets

-25.14%

Return on equity

-43.60%

Income statement

Revenue (ttm)

0.13

Revenue per share (ttm)

0.13

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-157,800,000.00

Net income to common (ttm)

-148,120,000.00

Diluted EPS (ttm)

-1.66

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

228.18M

Total cash per share (mrq)

2.52

Total debt (mrq)

26.64M

Total Debt/Equity (mrq)

9.47

Current ratio (mrq)

738.30%

Book value per share (mrq)

3.10

Cash flow

Cash flow statement

-124,109,000.00

Levered free cash flow (LFCF)

-78,726,872.00